The ATE nanoparticles contained an RNA aptamer (APT) capable of binding prostate-specific membrane antigen (PSMA), increasing their specificity for PCa cells that overexpress PSMA [210,211]. The gene discussed is FOLH1; the disease is posterior cortical atrophy.